1 / 35

TB pleural effusion

TB pleural effusion. 林倬睿醫師. Outlines . Introduction Etiology & pathogenesis Symptoms, laboratory & radiologic findings Diagnosis Treatment & management Complications . Introduction . 是由結核菌感染肋膜所引起 通常為 exudate, 可以同時合併肺部病灶 為最常見的肺外結核表現

valerian
Download Presentation

TB pleural effusion

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. TB pleural effusion 林倬睿醫師

  2. Outlines • Introduction • Etiology & pathogenesis • Symptoms, laboratory & radiologic findings • Diagnosis • Treatment & management • Complications

  3. Introduction • 是由結核菌感染肋膜所引起 • 通常為exudate, 可以同時合併肺部病灶 • 為最常見的肺外結核表現 • HIV患者若CD4數目較高,則TB pleural effusion發生率較高,可見TB pleural effusion的形成不只是感染,更是一種免疫反應(immunological response)

  4. Etiology & pathogenesis • Mycobacterial protein access pleural cavity through a rupture of a subpleural focus • TB protein  mesothelial/endothelial cells  cytokines neutrophils, lymphocytes, monocytes, etc • Pleural fluid: neutrophil in the early phase, highly suggestive of TB if lymphocyte > 85%

  5. Mycobacteria liposaccharides Mesothelial / endothelial cells IL-1, IL-6, TNF- α chemokines-α chemokines- MIP-1, MCP-1, TNF- α IL-8, NAP2 ADA1 Neutrophil, lymphocyte ADA2-ADA1 Activated lymphocyte Th1 Monocyte- macrophage Mycobacteria IL-1, TNF- α Mesothelial cell IL-12, IFN-ɤ

  6. Etiology & pathogenesis • HIV pt 因免疫反應差,在effusion中較常發現TB菌,biopsy中則較少見granuloma • Effusion的形成雖與免疫反應有關,但得到TB pleurisy不表示就因此產生抵抗力,若未治療,即使自然痊癒,將來仍有超過65%會發生active pulmonary TB • TB可以躲在macrophage中

  7. Symptoms • Male : female = 3 : 1 • Mostly < 35y/o or > 70y/o • Acute or subacute onset • S/S to diagnosis: < 1month • Cough, fever, chest pain, dyspnea • HIV pt: hepatosplenomegaly, LAP, less PPD (+)

  8. Laboratory findings • Non-specific (ESR , normal WBC) • Pleural effusion: • color : serofibrinous, serosanguinous • exudate • lymphocyte predominant • exclude TB, if : eosinophil > 10% mesothelial cell > 5%

  9. Radiological findings • Usually unilateral, small to moderate in size • 30% 的病人在同側肺實質有radiological disease • HIV pt 的effusion量較多,雙側有水的機會也比一般人高 • Primary: lower lobe involvement & LAP

  10. Diagnosis • Presumption: prevalence, HIV co-infection, pleural effusion, clinical symptoms • Definite diagnosis: • M. TB in sputum or effusion • caseous granulomas in the pleura

  11. P.E. with atelectasis • anechoic (C) complex nonseptated • (D) complex septated • (E) homogenously echogenic • (F) parapneumonic effusion • (G) malignant effusion

  12. Granuloma of Tuberculosis

  13. Diagnosis • Positive sputum culture rate: • 30–50% in pleural + lung involvement • only 4% in pleural involvement alone • Diagnostic methods: • pleural effusion culture: 23-86% • biopsy culture: 39-71% • presence of necrotizing caseous granuloma in biopsy: most efficient, 51-87% • all combined: 82-98%

  14. Diagnosis • Among HIV pt: • more positive sputum culture • more AFB (+) in pleural effusion • more positive biopsy culture • less granuloma formation

  15. Diagnosis • Conventional method: pleural biopsy • New methods: • finding TB: radiometric culture system, PCR • measure parameters caused by immunological-metabolic mechanism: adenosine deaminase (ADA), IFN-ɤ, etc

  16. Diagnosis • Radiometric culture system: • accelerate diagnosis by 2-3 weeks • PCR • rapid • identify the type of mycobacteria • determine susceptibility to drugs • not that reliable, requires QC procedure

  17. Diagnosis • ADA (adenosine deaminase) • Pleural TB infection  increased metabolic activity of the monocytes & macrophages  increased production of ADA • High levels of ADA: TB pleurisy, empyema, malignant lymphoma, collagen-vascular disease • Sensitivity: 77-100%, specificity: 81-97%

  18. Diagnosis • ADA (adenosine deaminase) • Association with L/N ratio > 0.75 or < 35y/o greatly improves the specificity • No differences with regard to HIV status • May be a better negative predictive parameter • ADA1: ubiquitous • ADA2: only in monocytes, macrophages

  19. Diagnosis • IFN-ɤ • relative good sensitivity & specificity • False positive: parapneumonic effusion, lymphoma, malignancy • Disadvantage: expensive, slow • Others • Lysozyme, tuberculostearic acid, monoclonal antibody, cytokines

  20. Treatment • Spontaneous resolution in 2-4 months in healthy individuals • 65% will develop pulmonary tuberculosis in 5 years • So, it is important to treat pleural tuberculosis

  21. Treatment • Should be monitored by official public health center • Ensure correct treatment • Prevent the emergence of resistant strain • Evaluation of contacts • Monitor the pattern of resistances • Provide education to the patients • Identify possible outbreaks

  22. Treatment • As pulmonary TB, combination therapy is preferred • Reducing the population of mycobacteria • Without creating resistance • Sterilizing the lesions during prolonged treatment phase

  23. Treatment • Duration: 6 month is recommended • Number of drugs: HRZ for 2 months, then HR for 4 months. • Add EMB if • Local resistance to INAH > 4% • High levels of resistance are reported • Received anti-TB drug previously • Exposed to MDR-TB patients

  24. Treatment • Some may show an increase of pleural effusion during the initial phase • Standard treatment is recommended for HIV patients. • If the clinical or bacteriological response is slow or less than optimal  prolong treatment

  25. Treatment • Use of steroid • Insufficient evidence to prove that steroid can reduce inflammation and subsequent residual pachypleuritis • 不如在診斷性抽水時把水抽乾一點

  26. Complications • Residual pleural thickening • Most frequent • Incidence varies according to the time of evaluation and the degree of thickness • No variable idetified • Minimal impact on lung functions

  27. Complications • Tuberculous empyema • Unusual, normally related to BP fistula • Response to medical treatment is limited • Frequently requires thoracotomy and/or decortication • May consider repeated thoracentesis with prolonged medical treatment • Thoracic wall infection • Rare, 1/106

  28. Thanks for your attention!

More Related